INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,751 | -10.0% | 109,897 | +3.3% | 0.01% | -12.5% |
| Q2 2023 | $47,509 | -69.3% | 106,397 | +7.2% | 0.01% | -74.2% |
| Q4 2022 | $154,889 | +21.0% | 99,288 | +34.1% | 0.03% | +19.2% |
| Q3 2022 | $128,000 | 0.0% | 74,058 | -0.2% | 0.03% | +4.0% |
| Q2 2022 | $128,000 | -50.8% | 74,172 | +2.4% | 0.02% | -43.2% |
| Q1 2022 | $260,000 | -21.5% | 72,422 | +9.0% | 0.04% | -18.5% |
| Q4 2021 | $331,000 | -26.8% | 66,422 | +5.1% | 0.05% | -34.1% |
| Q3 2021 | $452,000 | -19.7% | 63,172 | +4.1% | 0.08% | -19.6% |
| Q2 2021 | $563,000 | +7.9% | 60,712 | +7.9% | 0.10% | 0.0% |
| Q1 2021 | $522,000 | +50.9% | 56,255 | +44.0% | 0.10% | +41.7% |
| Q4 2020 | $346,000 | -8.2% | 39,075 | +20.3% | 0.07% | -22.6% |
| Q3 2020 | $377,000 | – | 32,475 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |